Patents
Patents for C07C 255 - Carboxylic acid nitriles (27,066)
09/2003
09/30/2003US6627046 From nylon carpet; distillation of hexamethylenediamine,adiponitrile, aminocapronitrile, and caprolactam monomers and reaction products
09/25/2003WO2003078561A1 Ammonium nitriles and the use thereof as hydrophobic bleaching activators
09/25/2003WO2003078385A1 Process for making 5-formylvaleronitrile using reactivated catalyst
09/25/2003WO2003078382A1 N-biphenylamides and fungicidal compositions containing the same
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003005010A3 Method for producing optically active cyanohydrins
09/25/2003WO2002100818A3 Aminediols as agents for the treatment of alzheimer's disease
09/25/2003US20030181751 Reacting 2-alkoxy-5,9-dodecadienone oxime or 2-halogeno-5,9-cyclododecadienone oxime with formic acid and hydroxylamine
09/25/2003US20030181731 Process for producing 5-fluorooxyindole and for producing intermediates therefor
09/25/2003US20030181688 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds
09/25/2003US20030181519 Substituted phenyl naphthalenes as estrogenic agents
09/25/2003US20030181445 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030181335 As an example, 3-(4-Cyano-3-methoxyphenyl)-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine -2,4-dione; very active herbicides and/or for the desiccation and/or defoliation of plants; better control of weeds
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/25/2003CA2456927A1 Ammonium nitriles and the use thereof as hydrophobic bleaching activators
09/24/2003EP1345972A2 Method for sterilizing cyanoacrylate compositions
09/24/2003EP1345906A2 Method for producing 4-haloalkyl nicotine nitriles
09/24/2003EP1345899A1 Compounds
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1345888A1 Method for the production of 1,5-naphthalenediamine
09/24/2003EP1137484B1 Raney cobalt catalyst and a process for hydrogenating organic compounds using said catalyst
09/24/2003EP0832072B1 Phenylpyridazinones
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444560A Amelioration of ammonia breakthrough in alkane ammoxidation process
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/24/2003CN1443755A Method for preparing p-fluorobenzonitrile by p-chlorobenzonitrile fluoro
09/24/2003CN1443754A Method for producing o-chlorobenzonitrile
09/24/2003CN1443753A Method for preparing 2,6-difluorobenzonitrile by using 2,6-dichlorobenzonitrile fluoro
09/24/2003CN1443752A Fluidized bed catalyst for preparing o-chlorobenzonitrile
09/24/2003CN1443734A Process for producing organic compound using nitrite
09/24/2003CN1122019C Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain of spinal trauma
09/23/2003USRE38257 Piperdine derivatives and hypotensives containing the same
09/23/2003US6624323 Process and intermediates for making 4-cyanosubstituted cyclohexanoic acids
09/23/2003US6624179 Geometrical isomers of acrylonitrile compounds, mixture thereof, and process for producing these
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624120 Substituted herbicidal phenyluracils
09/23/2003US6624111 Halogen promoted multi-metal oxide catalyst
09/23/2003US6623810 Refractive index anisotropy
09/23/2003CA2257346C Method for filtering a three-phased reaction mixture
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076394A1 Phosphonite ligands and their use in hydrocyanation
09/18/2003WO2003076382A1 Method for the measurement of the pressure in a gas phase from rectification and/or absorption columns comprising (meth)acrylic acid the esters and/or nitriles thereof
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003US20030176735 Catalyzing the dehydrogenation, follow by cyanomethylation, hydrolysis; as intermediate materials for making N-(phosphonomethyl)glycine agricultural chemical
09/18/2003US20030176734 Halogen promoted multi-metal oxide catalyst
09/18/2003US20030176720 Process for making 5-formylvaleronitrile using reactivated catalyst
09/18/2003US20030176506 For therapy of leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells
09/18/2003US20030176495 HIV Integrase inhibitors
09/18/2003US20030172470 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades.
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/17/2003EP1344774A1 Synthesizing methods of dicyanomethylidene compound and heterocyclic compound
09/17/2003EP1344770A1 Process for the hydrocyanation of butadiene
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1135208B1 Raney iron catalyst and a process for hydrogenating organic compounds using said catalyst
09/17/2003EP0997454B1 Method for gas phase catalytic oxidation of hydrocarbon
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443157A Process for purification and recovery of acetonitrile
09/17/2003CN1443137A Chemical process
09/17/2003CN1442404A Method of preparing p-cyanophenol like compound
09/17/2003CN1121392C Substituted pyrimidine (thi) ones
09/17/2003CN1121382C Improved acrylonitrile recovery process
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/17/2003CN1121374C Novel trienoic retinoid compounds and method
09/16/2003US6620960 Process for the preparation of substituted phenylacetonitriles
09/16/2003US6620944 Process for preparing pesticidal intermediates
09/16/2003US6620933 Dyes having acid reistance and stability used as colors for silver halide photographic, photosensitive materials, ink jet or thermal printing and as toners in electrophotography, electroluminescence or television displays
09/16/2003US6620920 Anisotropic polymers having branchings which can absorb electromagnetic waves, used for optical signal processing; birefringence
09/12/2003WO2003074448A2 Process for making organic products from non-product streams using a catalyst
09/12/2003WO2002053518A3 HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS
09/11/2003WO2003074449A2 Multi-substitued selective androgen receptor modulators and methods of use thereof
09/11/2003US20030171618 Process for producing organic compounds using nitrites
09/11/2003US20030171612 Method of preparing retroviral protease inhibitor intermediates
09/11/2003US20030171609 Aminonitrile production
09/11/2003US20030171592 A nitro ketone or a cyano ketone is reacted with a hydrogen-donor in the presence of a transition metal compound catalyst having an optically active nitrogen asymmetric ligand to form the alcohol and reducing to the amine
09/11/2003US20030171440 Tramadol analogs and uses thereof
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/11/2003US20030170178 For therapy and diagnosis of infectious diseases; diseases characterised by cellular hyperproliferation such as tumours, psoriasis, actinic keratosis, atheromas, endoarterial hyperplasia, prostate hyperplasia; for sterilization of blood
09/10/2003EP1342715A2 Process for producing oximes using nitirites
09/10/2003EP1341799A1 P-chirale bisphospholane ligands, their transition metal complexes
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1341752A1 Novel indanylidene compounds
09/10/2003EP1341751A1 tROCESS FOR MAKING 5-CYANOVALERIC ACID, ADIPIC ACID OR DIMETHYL ADIDPATE
09/10/2003EP1341750A1 Method for the carbonylation of pentenoic acid and derivatives thereof
09/10/2003EP1341746A1 Liquid crystalline compounds
09/10/2003EP1341743A2 Organic reactions with co generating materials
09/10/2003EP1341742A1 Method for producing compounds having a cf2o bridge
09/10/2003EP1127047B1 Hemihydrogenation method for dinitriles
09/10/2003EP1032557B1 Method for preparing bromomethyl-biphenyl derivatives
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003CN1441787A Modulators of TNF-alpha signaling